12-hexahydrobenzo(a)anthracene-1
12-hexahydrobenzo(a)anthracene-1 Uses, Dosage, Side Effects, Food Interaction and all others data.
12-hexahydrobenzo(a)anthracene-1 is under investigation in clinical trial NCT01047943 (STA-21 Topical Efficacy on Psoriasis).
| Trade Name | 12-hexahydrobenzo(a)anthracene-1 |
| Generic | Ochromycinone |
| Ochromycinone Other Names | (+)-ochromycinone, (3s)-3.beta.-methyl-8-hydroxy-1,2,3,4,7,12-hexahydrobenzo(a)anthracene-1,7,12-trione, Benz(a)anthracene-1,7,12(2h)-trione, 3,4-dihydro-8-hydroxy-3-methyl-, (s)- |
| Type | |
| Formula | C19H14O4 |
| Weight | Average: 306.317 Monoisotopic: 306.089208931 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here 12-hexahydrobenzo(a)anthracene-1
